Comparative Study of Efficacy and Safety of Intravenous Labetalol and Intravenous Hydralazine in managing Hypertensive Emergencies in Pregnancy
Richa Singh, Sneha Anand, Neeraj Kumar Yadav
Citation Information :
Singh R, Anand S, Yadav NK. Comparative Study of Efficacy and Safety of Intravenous Labetalol and Intravenous Hydralazine in managing Hypertensive Emergencies in Pregnancy. J South Asian Feder Obs Gynae 2016; 8 (3):185-188.
Update on die use of antihypertensive drugs in pregnancy. Hypertension 2008 Apr;51(4):960-969.
Lippincott's illustrated reviews: Pharmacology. 2nd ed. Philadelphia: Lipincott, Williams & Wilkins; 2000. 190 p.
ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33. Obstet Gynecol 2002 Jan;99(1):159-167.
WHO evidence and information for policy. In: Global burden of hypertensive disorders of pregnancy in year 2000. p. 1-7.
Adverse effects of dihydralazine and diazide therapy. S Afr Med J 1981;59:496-597.
Acute effects of labetalol on maternal metabolism and uteroplacental circulation in hypertension of pregnancy. In: Riley A, Symond EM (editors). The investigation of labetalol in the management of hypertension in pregnancy (International Congress series No. 591). Amsterdem: Excerpta Medica; 1981. p. 36.
A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987 Sep;70(3 Pt 1):328-333.
Comparison of labetalol and dihydralazine in hypertensive emergency of pregnancy. S Afr Med J 1987 Mar;71(6):354-356.
